Cannabis in Japan

Cannabis in Japan

Currently, there are no sales of medical cannabis in Japan, although the illegal cannabis market continues to grow, along with legal CBD & other non-intoxicating cannabinoids. However, an amendment to Japan’s Cannabis Control Law was passed in December 2023, which will allow for the domestic use of medicines made from cannabis plants. It also allows for the cultivation of cannabis plants for the purpose of collecting raw materials for medicinal products, which was previously only permitted for t...

Euromonitor International's Cannabis in Japan market report offers a comprehensive guide to the size and shape of this emerging market opportunity at a national level. It provides the latest retail sales data (historic date range), allowing you to identify the key cannabinoid categories driving growth. It outlines the regulatory, cultural and commercial context and offers strategic analysis of key factors influencing the market – legislative developments both current and future, economic/lifestyle influences, illicit consumption, product innovation, distribution and pricing trends. Forecasts to 2028 illustrate how the market is set to expand and change.

Product coverage: Adult-Use Cannabis, CBD & Other Non-Intoxicating Cannabinoids, Medical Cannabis.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Cannabis market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.